A research group has developed a new COVID-19 testing system using Janus particles — microparticles with two sides possessing distinctive molecular properties. These particles are engineered to bind specifically to target antigens, such as viral proteins, creating a low-cost, accurate, and rapid means of testing for viral diseases. The system’s versatility means it can potentially be used to test for other diseases and biomarkers linked to other conditions.
Geiger Mueller News Service